输血依赖的非严重无形性贫血:临床特征和结果
Yawen Zhang1, Yao He2, Suli Wang3
1Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China.
Frontiers in immunology
|July 27, 2023
概括
输血依赖的非严重无形性贫血 (TD-NSAA) 通常会发展为严重无形性贫血 (SAA) 并导致器官损伤. 强化免疫抑制疗法用抗细胞球蛋白 (ATG) 显示出改善TD-NSAA患者的结果的希望.
科学领域:
- 血液学 血液学 血液学
- 内部医学 内部医学
- 临床研究 临床研究
背景情况:
- 输血依赖的非严重无形性贫血 (TD-NSAA) 是一种罕见的骨髓衰竭综合征,其特征和预后尚不清楚.
- TD-NSAA可以长期存在或进展到严重的无形成性贫血 (SAA).
研究的目的:
- 调查TD-NSAA患者的临床和实验室特征,预后和结果.
- 评估TD-NSAA不同治疗策略的疗效.
主要方法:
- 对124名TD-NSAA患者的临床和实验室数据的回顾性分析.
- 评估并发症,SAA的进展和治疗反应.
主要成果:
- 常见的并发症包括铁过载,肝/功能障碍和严重的感染.
- 58%的患者进展到SAA,其中绝对中性粒细胞数量较低,严重感染或铁过载预测进展.
- 与单独的CsA (19.3%) 相比,抗血球蛋白 (ATG) 加上环素A (CsA) 显示出较高的整体反应率 (56.7%).
结论:
- TD-NSAA的特点是长期的疾病过程,严重的器官损伤,以及进展到SAA的高风险.
- 强化免疫抑制疗法,特别是基于抗肌球蛋白 (ATG) 的疗法,似乎对TD-NSAA管理有益.
- 观察到二次克隆性血液病和死亡率,突出显示需要警监测和有效治疗.
相关概念视频
Bone Marrow Sampling and Transplants
360
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
360
Blood Transfusion
615
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
615
Blood Transfusion and Agglutination
10.9K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.9K
Chronic Kidney Disease II: Clinical Manifestations
32
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
32
Acute Kidney Injury III: Clinical Manifestations
34
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
34
Tissue Transplantation
398
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
398


